Home / Companies / News / Tech transfer of Russian Covid vaccine Sputnik V kicks off at Indian sites

Tech transfer of Russian Covid vaccine Sputnik V kicks off at Indian sites

In September, DRL and RDIF had tied up to conduct clinical trials and distribute the vaccine in India.

Premium

Sources said within a couple of months a new version of the Sputnik V would be developed that could be stored at a temperature range of 2 to 8 degrees Celsius.

Sohini Das Mumbai

2 min read Last Updated : Nov 20 2020 | 10:23 PM IST

As the first batch of the Russian Covid-19 vaccine Sputnik V arrives in India for clinical trials, the process of technology transfer is on at partner sites of Hyderabad-based pharma major Dr Reddy’s Laboratories (DRL). According to sources, work is on to develop a new version of this vaccine that can be stored at 2 to 8 degrees Celsius. Currently, the vaccines’ cold storage requirements are -18 degrees Celsius.

Russian Direct Investment Fund (RDIF) and DRL have tied up for conducting clinical trials of the vaccine candidate in India as well as DRL will also be responsible for distribution

Topics : Coronavirus Vaccine Pharma Companies

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in